FindTrial
Sign In

Prolotherapy In Patient Of Osteoarthritis Knee Pain

Clinical study of two different doses of dextrose as a drug for prolotherapy treatment in patients of osteoarthritis knee pain - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076163
Enrollment
60
Registered
2024-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

Department of anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age groups 45 years - 75 years 2. Patients of both SEX 3. ASA Grade I & II 4. OA knee grade II &III

Exclusion criteria

Exclusion criteria: 1. Uncontrolled metabolic disease(DM2 ,Thyroid disease) 2. Patients with implants 3. Pregnancy 4. Know drug allergy 5. Cardiac diseases.

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of two concentration of dextrose 10% and 25% for intraarticular injection in osteoaethritis knee pain.Timepoint: Outcome will be assessed at after the procedure,at 1month,3month,6month—

Secondary

MeasureTime frame
To determine the effectiveness of dextrose prolotherapy as long term treatment for chronic musculoskeletal knee painTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Rajkumar Ahirwal

Gandhi Medical College, Bhopal

singhdrjaideep@gmail.com9827767022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026